Clinical Evaluation of Deferasirox For Removal of Cr+6 Ions In Rats

Abstract

The present research aimed to characterize the potential efficiency of deferasirox in removing chromium after its administration for 60 days following two doses of 15 and 30 mg/kg Cr+6 to the body weight of the male Wistar rats every day. After chromium administration some abnormal clinical signs such as red staining around the eyes, greenish mottling on the liver, weakness and loss of hair and weight, were observed in rats. Deferasirox was given orally to different groups of rats for a period of one week immediately after chromium administration. After chelation therapy, animals were anesthetized with ether vapors and then chromium and iron concentrations in various tissues were determined by graphite furnace and flame atomic absorption spectrometry methods, respectively. The chelation therapy results showed that deferasirox was able to remove chromium ions from the body and at the same, iron levels in tissues and clinical symptoms were also reduced.

Authors and Affiliations

Marzieh Iranmanesh

Keywords

Related Articles

Drug Design and Analysis In Silico of Sapelenin G, an Acyclic Triterpenoid as Potential Anti-Inflammatory

Diverse non-steriodal anti-inflammatory drugs and COX-2 inhibitors are a class of drugs which selectively inhibit COX-2, provide relief from pain and inflammation. However, they lack anti-thrombotic activity and hence le...

Drug-Induced Delirium from a Suspected Drug-Drug Interaction between Promethazine and Ketorolac

Case: An 18 year old female with no psychiatric history experiences delirium following the administration of promethazine and ketorolac which resolves following the discontinuation of both medications. The pathophysiolog...

Iron Chelating and Antioxidant Activities and Cytotoxicity Effect of the Pistachio (Pistachio vera L.) hull and kernel Extracts in the A549, HT29 and MCF-7 Cancerous Cell lines

Synthetic iron-chelators have been considered for treatment of some clinical situations such as iron overloading and cancer. However, their side effects and incomplete effectiveness limit their usages. Natural products c...

Tragedies in Clinical Trials - A History Wrapped Up

Today foremost emphasis is being given to the protection of patient’s safety and ethics during the conduct of clinical trials. Serious considerations by regulatory authorities are taken to safeguard the patient’s right,...

Evaluation of Leukocyte DNA Damage and Antioxidant Defense in Graves’ Disease; Effect of Medical Treatment

Background: Oxidative stress has been implicated in many pathological conditions, including hyperthyroidism. In this study, our aim was to investigate the effect of medical treatment on oxidative/antioxidative status and...

Download PDF file
  • EP ID EP201628
  • DOI 10.19070/2167-910X-1300018
  • Views 72
  • Downloads 0

How To Cite

Marzieh Iranmanesh (2013). Clinical Evaluation of Deferasirox For Removal of Cr+6 Ions In Rats. International Journal of Clinical Pharmacology & Toxicology(IJCPT), 2(7), 97-101. https://europub.co.uk/articles/-A-201628